Literature DB >> 20618774

Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.

P Pradhan-Palikhe1, P Vikatmaa, T Lajunen, A Palikhe, M Lepäntalo, T Tervahartiala, T Salo, P Saikku, M Leinonen, P J Pussinen, T Sorsa.   

Abstract

Matrix metalloproteinases are responsible for degradation and remodelling of extracellular matrix and exert important roles in initiation and progression of inflammatory diseases. We aimed to examine the role of Matrix metalloproteinases (MMPs) and their regulators in degenerative arterial diseases. Serum samples were collected from patients with arterial disease (n = 126), who underwent surgery because of symptomatic aorto-occlusive disease (AOD, n = 18), carotid artery stenosis (n = 67) or abdominal arotic aneurysm (n = 41). Serum MMP-1, MMP-8, MMP-13, TIMP-1, myeloperoxidase (MPO) and neutrophil elastase (HNE) concentrations were determined by ELISA, and the molar ratio of MMP-8 and TIMP-1 was calculated. To get reference values, the determinations were done on samples of healthy blood donors (n = 100). In univariate analyses, the patients had higher MMP-8 (P < 0.001), TIMP-1 (P = 0.045), and MMP-8/TIMP-1 (P < 0.001), and lower MPO (P < 0.001) when compared with the blood donors. All three subgroups had higher MMP-8 (P < 0.001) and MMP-8/TIMP-1 (P < 0.001), and lower MPO (P < 0.01, except AOD) levels when compared with the references. In multiple logistic regression analyses, the male gender (P < 0.01), age (P < 0.001), elevated MMP-8 (P < 0.001) and decreased MPO (P < 0.001) concentrations associated significantly with the risk for arterial disease, and provided an area under curve (AUC) of 0.97 in the Receiver operating characteristics analyses. In multiple linear regression analyses, HNE correlated with both MMP-8 (P < 0.001) and MPO (P = 0.008) concentrations. Combination of high MMP-8 and low MPO level in serum eventually reflecting selectively modified neutrophil degranulation may indicate increased risk for arterial disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618774     DOI: 10.1111/j.1365-3083.2010.02418.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  14 in total

Review 1.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

2.  Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

Authors:  Yanwen Qin; Xu Cao; Jun Guo; Yaozhong Zhang; Lili Pan; Hongjia Zhang; Huihua Li; Chaoshu Tang; Jie Du; Guo-Ping Shi
Journal:  Cardiovasc Res       Date:  2012-08-07       Impact factor: 10.787

3.  Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome.

Authors:  Vibhav Sekhsaria; Lori E Dodd; Amy P Hsu; Jennifer R Heimall; Alexandra F Freeman; Li Ding; Steven M Holland; Gulbu Uzel
Journal:  J Allergy Clin Immunol       Date:  2011-08-27       Impact factor: 10.793

4.  Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia.

Authors:  Giovanni De Caridi; Mafalda Massara; Francesco Spinelli; Antonio David; Sebastiano Gangemi; Francesco Fugetto; Raffaele Grande; Lucia Butrico; Roberta Stefanelli; Manuela Colosimo; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-05-27       Impact factor: 3.315

5.  Morphological changes of cerebral vessels and expression patterns of MMP-2 and MMP-9 on cerebrovascular wall of alcoholic rats.

Authors:  Qian Qi; Xia Liu; Guozhong Zhang; Wenjing He; Rufei Ma; Bin Cong; Yingmin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Ascending Aortic Proaneurysmal Genetic Mutations with Antiatherogenic Effects.

Authors:  Alexander Curtis; Tanya Smith; Bulat A Ziganshin; John A Elefteriades
Journal:  Int J Angiol       Date:  2015-08-17

Review 7.  STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.

Authors:  Christo Tsilifis; Alexandra F Freeman; Andrew R Gennery
Journal:  J Clin Immunol       Date:  2021-05-01       Impact factor: 8.317

Review 8.  The role of novel atherosclerosis markers in peripheral artery disease: is there a gender difference?

Authors:  Hora Iu Comşa; Dumitru Zdrenghea; Sorin Claudiu Man; Dana Pop
Journal:  Cardiovasc J Afr       Date:  2018-04-20       Impact factor: 1.167

Review 9.  An update on the hyper-IgE syndromes.

Authors:  Patrick F K Yong; Alexandra F Freeman; Karin R Engelhardt; Steven Holland; Jennifer M Puck; Bodo Grimbacher
Journal:  Arthritis Res Ther       Date:  2012-11-30       Impact factor: 5.156

10.  Salivary biomarkers for detection of systemic diseases.

Authors:  Nilminie Rathnayake; Sigvard Akerman; Björn Klinge; Nina Lundegren; Henrik Jansson; Ylva Tryselius; Timo Sorsa; Anders Gustafsson
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.